Lung cancer drugs may stress the heart – new study investigates
NCT ID NCT07267247
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study followed 100 people with advanced EGFR-mutant lung cancer who were taking drugs called EGFR-TKIs (erlotinib, dacomitinib, afatinib, or osimertinib). The goal was to see how often these drugs cause heart problems, specifically a drop in the heart's pumping ability. Researchers measured heart function before and during treatment to track any changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EGFR-TKI drugs (erlotinib, dacomitinib, afatinib, osimertinib)
- What this could lead to
- If successful, this could help doctors better monitor and prevent heart side effects in lung cancer patients taking these drugs.
- What could go wrong
- This is a small, single-center observational study, so results may not apply to all patients. It only measures heart function changes, not whether these changes cause symptoms or affect survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Taichung Veterans General Hospital
Taichung, 407, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a PET scan reveal hidden heart harm from lung cancer treatment?
- Chemotherapy's hidden heart toll: study probes lasting damage in breast cancer survivors
- Genetic panel aims to spot heart risk before cancer therapy begins
- Heart-Safe chemo? trial aims to shield patients from lifelong damage
- Blood test may shield cancer Patients' hearts from chemo damage
- AI-Powered patch could replace ultrasound for heart checkups